Prognostic Value of Peripheral Blood Parameters in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer

1

Breast cancer is the leading cause of cancer mortality among women, highlighting the need for effective prognostic tools.
2

Inflammatory markers like NLR and PLR are associated with worse disease-free survival and overall survival in breast cancer patients.
3

This study evaluates the prognostic value of peripheral blood parameters in patients undergoing neoadjuvant chemotherapy for breast cancer.
4

The study population included patients treated at Asan Medical Center from 2007 to 2013, with long-term follow-up until March 2023.
5

Pathological complete response and survival outcomes were assessed to determine the clinical significance of blood biomarkers.

Bmc Cancer

by Tae-in Yoon, Seunghee Baek, Ji hyeon Lee, Tae Kyung Yoo, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Sae Byul Lee
January 3, 2026

1